Itrenza is rational therapy with the right dose and right pack in VVC and tinea infections. Itrenza has higher clinical cure rate and lower relapse rate as compared to fluconazole. Itrenza is the first line of treatment for vaginal candidiasis with effective dose of 200 mg OD for three days and 200 mg OD for 7 - 10 days in tinea infection
Itrenza is used in tinea infections and Vulvovaginal candidiasis
* To be consumed as directed by physician.